1. Home
  2. ONEW vs ADCT Comparison

ONEW vs ADCT Comparison

Compare ONEW & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$11.15

Market Cap

176.6M

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$3.40

Market Cap

431.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONEW
ADCT
Founded
2014
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.6M
431.2M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
ONEW
ADCT
Price
$11.15
$3.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$16.50
$7.75
AVG Volume (30 Days)
113.7K
1.0M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.86
EPS
2.77
N/A
Revenue
$1,872,334,000.00
$81,357,000.00
Revenue This Year
$0.30
N/A
Revenue Next Year
$3.14
$66.49
P/E Ratio
$4.07
N/A
Revenue Growth
5.62
14.85
52 Week Low
$8.12
$2.55
52 Week High
$17.92
$4.98

Technical Indicators

Market Signals
Indicator
ONEW
ADCT
Relative Strength Index (RSI) 54.94 42.67
Support Level $11.00 $3.37
Resistance Level $12.31 $3.59
Average True Range (ATR) 0.59 0.17
MACD 0.02 0.02
Stochastic Oscillator 60.27 46.72

Price Performance

Historical Comparison
ONEW
ADCT

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: